DK2068899T3 - Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner - Google Patents

Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner Download PDF

Info

Publication number
DK2068899T3
DK2068899T3 DK07838266.0T DK07838266T DK2068899T3 DK 2068899 T3 DK2068899 T3 DK 2068899T3 DK 07838266 T DK07838266 T DK 07838266T DK 2068899 T3 DK2068899 T3 DK 2068899T3
Authority
DK
Denmark
Prior art keywords
existence
duration
reduce
lactobacillus acidophilus
infections
Prior art date
Application number
DK07838266.0T
Other languages
Danish (da)
English (en)
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2068899(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK2068899T3 publication Critical patent/DK2068899T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK07838266.0T 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner DK2068899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02
PCT/US2007/020033 WO2008042101A2 (en) 2006-10-02 2007-09-14 Probiotics for use in reducing the incidence and duration of illness

Publications (1)

Publication Number Publication Date
DK2068899T3 true DK2068899T3 (da) 2015-09-28

Family

ID=39268947

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07838266.0T DK2068899T3 (da) 2006-10-02 2007-09-14 Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner
DK14186663.2T DK2839836T4 (da) 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14186663.2T DK2839836T4 (da) 2006-10-02 2007-09-14 Probiotika til anvendelse til reduktion af symptomer på luftvejssygdom

Country Status (13)

Country Link
US (5) US20100040579A1 (enExample)
EP (2) EP2839836B2 (enExample)
JP (3) JP5896589B2 (enExample)
KR (2) KR101474188B1 (enExample)
CN (1) CN101528244B (enExample)
AU (1) AU2007302715B2 (enExample)
BR (1) BRPI0719787A2 (enExample)
DK (2) DK2068899T3 (enExample)
ES (2) ES2650375T5 (enExample)
FI (1) FI2839836T4 (enExample)
MX (1) MX2009003260A (enExample)
PL (2) PL2068899T3 (enExample)
WO (1) WO2008042101A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2835860B1 (en) 2009-12-02 2018-03-07 KMW Inc. Device selection structure
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
ES2856013T3 (es) 2013-11-15 2021-09-27 Nestle Sa Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
MX380540B (es) 2015-03-05 2025-03-12 Soc Des Produits Nestle S A Star Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
WO2020170982A1 (ja) 2019-02-21 2020-08-27 オリンパス株式会社 フローラ治療用留置体、フローラ治療法
WO2021062250A1 (en) 2019-09-25 2021-04-01 Tall Goods, Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
DE69737420T2 (de) * 1996-11-29 2007-11-15 Bio K + International Inc., Montreal Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
OA13142A (en) 2002-10-11 2006-12-13 Wyeth Corp Nutritional formulations containing synbiotic substances.
US20090257993A1 (en) * 2003-12-17 2009-10-15 M Rabet Laura Lactic Acid Producing Bacteria and Lung Function
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2006088923A2 (en) * 2005-02-15 2006-08-24 Gorbach Sherwood L A food containing a probiotic and an isolated beta-glucan and methods of use thereof
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
KR101300086B1 (ko) 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도

Also Published As

Publication number Publication date
KR20140002069A (ko) 2014-01-07
JP2010505824A (ja) 2010-02-25
PL2839836T3 (pl) 2018-02-28
KR101485200B1 (ko) 2015-01-26
CN101528244A (zh) 2009-09-09
US20140356329A1 (en) 2014-12-04
JP2014058558A (ja) 2014-04-03
PL2839836T5 (pl) 2025-11-17
DK2839836T4 (da) 2024-08-26
MX2009003260A (es) 2009-05-11
WO2008042101A3 (en) 2009-04-09
US20230256037A1 (en) 2023-08-17
FI2839836T4 (fi) 2024-08-26
AU2007302715B2 (en) 2013-01-31
DK2839836T3 (en) 2017-12-04
EP2068899A2 (en) 2009-06-17
AU2007302715A1 (en) 2008-04-10
EP2839836B2 (en) 2024-06-26
EP2839836B1 (en) 2017-08-30
US20100040579A1 (en) 2010-02-18
CN101528244B (zh) 2012-01-11
JP5896589B2 (ja) 2016-03-30
BRPI0719787A2 (pt) 2014-11-25
PL2068899T3 (pl) 2015-12-31
US20180000875A1 (en) 2018-01-04
US20200316145A1 (en) 2020-10-08
ES2650375T3 (es) 2018-01-18
KR101474188B1 (ko) 2014-12-17
EP2839836A1 (en) 2015-02-25
ES2547480T3 (es) 2015-10-06
KR20090063222A (ko) 2009-06-17
JP2016128478A (ja) 2016-07-14
WO2008042101A2 (en) 2008-04-10
EP2068899B1 (en) 2015-07-01
ES2650375T5 (en) 2025-02-03

Similar Documents

Publication Publication Date Title
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK2181330T3 (da) Sammensætninger og midler til diagnosticering af mikrobielle infektioner
DK2209806T3 (da) Anti-hepcidin-antistoffer og anvendelser deraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
PL2099826T3 (pl) Przeciwciało przeciwko beta-amyloidowi i jego zastosowania
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
BRPI0819573A2 (pt) Composição e artigo
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2222706T3 (da) Antibodies against human nkg2d and uses thereof
DK3586901T3 (da) Kateteriseringsindretning og kit
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
PL2256063T3 (pl) Urządzenie rozpylające oraz sposób użycia urządzenia rozpylającego
CR20130360A (es) Compuesto heterocíclico y su uso
EP2500372A4 (en) FOIL AND ITS APPLICATION
DK2172515T3 (da) Gummiforbindelse og støbt artikel
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2328931T3 (da) Selektive anti-hepcidin-25-antistoffer og anvendelser deraf
HRP20141261T1 (xx) Spojevi tioninija i njihove uporabe
IL200576A0 (en) Inhibitors of rtp801 and their uses
PL2214656T3 (pl) Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
DK2087094T3 (da) Lactobacillus fermentum ess-1, dsm17851 og dets anvendelse til behandlingen og/eller forebyggelse af candidiasis og urinvejsinfektioner
DK2176284T3 (da) Lantibiotika og anvendelser deraf
FI20060955L (fi) Sakeutuslaite ja -menetelmä
DK3269358T3 (da) Sammensætning til topisk anvendelse, anvendelser heraf, applikatorindretning og sæt af dele
DE602007006888D1 (de) Leistungsumwandlungssystem und -verfahren